Diplomat Pharmacy (DPLO) Misses Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Diplomat Announces 4th Quarter and 2016 Year End Financial Results; Provides Initial 2017 Guidance
February 28, 2017 4:16 PM ESTFLINT, Mich., Feb. 28, 2017 /PRNewswire/ --Â Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter and year ended December 31, 2016. Â All comparisons, unless otherwise noted, are to the quarter or year ended December 31, 2015.
Fourth Quarter 2016 Highlights include:
Revenue of $1,145 million, an increase of 16% or $158 million 4% organic revenue growth Total prescriptions dispensed of 242,000, an increase of 2% Gross margin of 7.3% versus 7.8% Gross profit per prescription dispensed... More